A Data-Driven, 
 Dynamic Launchpad 
 for Next-Generation Agentic Solutions.

A Data-Driven, 

Dynamic Launchpad 

for Next-Generation
Agentic Solutions.

The Phluence™ Platform

The Phluence Platform delivers a new class of patient experience by integrating three distinct layers that involve AI agents for healthcare, robust data analytics, and multiple complex data sources, including longitudinal patient data. From this single, powerful healthcare AI platform multiple solutions can be assembled to execute patient services functions. The result is a tech- first system that excels at managing complex workflows, 24 hours a day, 7 days a week, without increasing the human footprint of a manufacturer’s patient services operation.

ACTION
AGENTS

ACCESS
AGENTS

LONGITUDINAL
DATA

A Library of Action Agents Autonomously Perform a Variety of Tasks, Guided by Patient-Specific and Longitudinal Data.

Phluence Action Agents are AI agents for healthcare that autonomously perform Patient Support tasks with minimal human input and guided by patient-specific data acquired by the Access Agent. Examples of our Action Agents include Eligibility Agents, Alternate Coverage Agents, Pharmacy Agents, and more.
  • Choose from a library of prebuilt agents designed by Phluence engineers based on our extensive market access experience.
  • Build custom action agents based on your unique brand, market, or patient experience needs.
  • Integrate or daisy-chain action agents as needed to execute and automate complex workflows, including escalation to human agents.

The Phluence Access Agent Unlocks Temporal Intelligence, Capturing a Picture of a Patient 
in a Moment of Time.​

Personalization is central to Phluence, and the Phluence Access Agent uses tokenization to unlock insights at the patient level by connecting to and parsing patient-level data, represented in the layer below. Armed with this information, Phluence Action Agents can provide truly personalized experiences.
  • Tap into unprecedented temporal intelligence to understand exactly where a patient is on their specific post-prescription journey.
  • Apply patient-centric data in healthcare to every decision, improving next best action
    models and shifting engagement to a proactive, always-on model that balances patient needs with clinical goals.
  • Map more complete patient pathways, connecting to hospital records, pharmacy claims, and even wearable device data, while maintaining individual privacy.

Longitudinal Data from Multiple Sources Provides Context on Drug, Disease State & Reimbursement Dynamics.

Patient-specific longitudinal healthcare insights, extracted from third-party data, patient analytics, and case management solutions, reveal a clear picture of a patient’s medical history and the patient’s experience with the healthcare system, including prescribing behaviors.
  • Access multiple, disparate data sources — electronic health records, pharmacy claims, and patient registries — to build a clearer, more accurate picture of a patient over a defined period of time.
  • Context is critical in healthcare decision-making — follow a patient across multiple touchpoints to determine exactly where they are on their care journey.
  • Make better decisions by monitoring key patient journey events, such as predicting and preventing drop-off, identifying hidden coverage gaps, and tailoring financial assistance

How can the Phluence™
AI Healthcare Platform help you?

Phluence infuses its expertise in patient engagement with healthcare data from multiple sources to build powerful, patient- focused solutions. We can help you, too.
*Required fields

Please read our Privacy Policy to see how we use your personal information.

News & Insights

What AFPs Are, How They Evolved, and Why They Matter Now

Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue & Patient Care Alternate Funding Programs have evolved into a powerful but largely invisible force in specialty pharma—reshaping patient access, distorting brand

Recent Articles

Part 1 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 23, 2026

Part 2 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 23, 2026

Part 3 of Our AFP Intelligence Series: The Hidden Threat to Specialty Brand Revenue &...

April 23, 2026

The Emerging Prerequisite to Drug Affordability: Digital Patient Engagement Drug affordability is one of the...

April 21, 2026